High-risk human papillomavirus (HPV) infection and cervical cancer prevention in Britain: Evidence of differential uptake of interventions from a probability survey

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 5, 2015, Pages 842-853

  Tanton, Clare ^a   Soldan, Kate ^b   Beddows, Simon ^b   Mercer, Catherine H ^a   Waller, Jo ^a   Field, Nigel ^a   Clifton, Soazig ^a,c   Copas, Andrew J ^a   Panwar, Kavita ^b   Manyenga, Precious ^b,e   Da Silva, Filomeno ^b,f   Wellings, Kaye ^d   Ison, Catherine A ^b   Johnson, Anne M ^a   Sonnenberg, Pam ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c NATIONAL CENTRE FOR SOCIAL RESEARCH   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f Ministerio de Interior   (Angola)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ASIAN; BRITISH ASIAN; CANCER PREVENTION; ETHNICITY; FEMALE; GREAT BRITAIN; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SCREENING; SMOKING; URINE; UTERINE CERVIX CANCER; VACCINATION; ADVERSE EFFECTS; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROBABILITY; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH SURVEYS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROBABILITY; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; UNITED KINGDOM; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84982282649     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-1333     Document Type: Review

References (46)

1. Bosch FX, de Sanjose S. Human papillomavirus in cervical cancer. Curr Oncol Rep 2002;4:175-83.
2. Cancer Research UK. Cervical cancer incidence statistics [Internet]. London: Cancer Research UK; 2011. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/incidence
3. Cancer Research UK. Cervical cancer key stats [Internet]. London: Cancer Research UK; 2011. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/cervical-cancer/uk-cervical-cancer-statistics
4. International Agency for Research on Cancer. Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon: International Agency for Research on Cancer; 2012. Available from: http://globocan. iarc.fr/Pages/fact-sheets-cancer.aspx
5. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. The Lancet 2004;364:249-56.
6. Health and Social Care Information Centre, Screening and Immunisations team. CervicalScreeningProgramme, England2011-12 [Internet]. TheHealth and Social Care Information Centre; 2012. Available from: http://www.cancerscreening.nhs.uk/cervical/cervical-statistics-bulletin-2011-12.pdf
7. Shack L, Jordan C, Thomson CS, Mak V, Møller H. UK Association of Cancer Registries. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 2008;8:271.
8. Currin LG, Jack RH, Linklater KM, Mak V, Møller H, Davies EA. Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health 2009;9:62.
9. Department of Health. Cancer reform strategy. London: DH; 2007.
10. Department of Health. Improving outcomes: a strategy for cancer. London: DH; 2011.
11. Foley G, Alston R, Geraci M, Brabin L, Kitchener H, Birch J. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer 2011;105:177-84.
12. Lancuck L, Patnick J, Vessey M. A cohort effect in cervical screening coverage? J Med Screen 2008;15:27-9.
13. Department of Health. Annual HPV vaccine uptake in England: 2010/11 [Internet] 2012. Available from: http://media.dh.gov. uk/network/211/files/2012/03/120319-HPV-UptakeReport2010-11-revised-acc.pdf
14. Hughes A, Mesher D, White J, Soldan K. Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2014;19.
15. Cottrell S, Roberts R, Thomas D. Factors affecting uptake of HPV vaccination in Wales. University of Warick; 2012.
16. Sinka K, Kavanagh K, Gordon R, Love J, Potts A, Donaghy M, et al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland. J Epidemiol Community Health 2014;68:57-63.
17. Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1795-806.
18. Erens B, Phelps A, Clifton S, Mercer CH, Tanton C, Hussey D, et al. Methodology of the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect 2014;90:84-9.
19. Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, Clifton S, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1781-94.
20. Payne RA, Abel GA. UK indices of multiple deprivation - a way to make comparisons across constituent countries easier. Health Stat Q Off Natl Stat 2012;22-37.
21. Sutton S, Rutherford C. Sociodemographic and attitudinal correlates of cervical screening uptake in a national sample of women in Britain. Soc Sci Med 2005;61:2460-5.
22. Field N, Tanton C, Mercer CH, Nicholson S, Soldan K, Beddows S, et al. Testing for sexually transmitted infections in a population-based sexual health survey: development of an acceptable ethical approach. J Med Ethics 2012;38:380-2.
23. Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, et al. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 2011;83:1744-51.
24. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
25. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16, 563 women with cervical carcinoma and 33, 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119:1108-24.
26. Bowman JA, Redman S, Dickinson JA, Gibberd R, Sanson-Fisher RW. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research. Health Serv Res 1991;26:97-107.
27. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 2003;12:1182-7.
28. Moser K, Patnick J, Beral V Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ 2009;338:b2025.
29. Klungsøyr O, Nygard M, Skare G, Eriksen T, Nygard JF. Validity of self-reported Pap smear history in Norwegian women. J Med Screen 2009;16:91-7.
30. Stupiansky NW, Zimet GD, Cummings T, Fortenberry JD, Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 2012;50:103-5.
31. Craig R, Mindell J. Health Survey for England 2010 - volume 1: respiratory health. Leeds: The NHS Information Centre; 2011.
32. Park A, Clery E, Curtice J, Phillips M, Utting D eds. British Social Attitudes: the 28th report. London: NatCen Social Research; 2012.
33. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009;16:199-204.
34. Enerly E, Olofsson C, Nygard M. Monitoring human papillomavirus prevalence in urine samples: a review. Clin Epidemiol 2013;5:67-79.
35. Pathak N, Dodds J, Zamora J, Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ 2014;349:g5264.
36. Fisher H, Audrey S, Mytton JA, Hickman M, Trotter C. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. J Public Health Oxf Engl 2014;36:36-45.
37. Roberts SA, Brabin L, Stretch R, Baxter D, Elton P, Kitchener H, etal. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011;139:400-5.
38. Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008;337:a769.
39. International Collaboration of Epidemiological Studies of Cervical Cancer Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13, 541 women with carcinoma ofthe cervix and 23, 017 women without carcinoma ofthe cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
40. Bowyer HL, Dodd RH, Marlow L A V, Waller J. Association between human papillomavirus vaccine status and other cervical cancer risk factors. Vaccine 2014;32:4310-6.
41. Fish J, Anthony D. UK national Lesbians and Health Care Survey. Women Health 2005;41:27-45.
42. Bailey JV, Kavanagh J, Owen C, McLean KA, Skinner CJ. Lesbians and cervical screening. Br J Gen Pract 2000;50:481-2.
43. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93.
44. Castanon A, Landy R, Cuzick J, Sasieni P. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: populationbased case control study. PLoS Med 2014;11:e1001585.
45. National Cancer Intelligence Network. Cancer Incidence and Survival By Major Ethnic Group, England, 2002-2006 [Internet]; London: 2006. Available from: http://www.ncin.org.uk/view?rid=75.
46. NHS Cervical Screening Programme. NHS Cervical Screening Programme: Annual Review 2012 [Internet]. Sheffield; 2012. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/cervical-annualreview-2012.pdf